|
Mr. Hull has been a director since 2005. Mr. Hull has nearly three decades of experience in the field of sales and marketing. Mr. Hull joined GlaxoSmithKline, a world leading research-based pharmaceutical company in October 1987 and is currently Senior Vice President for the US Pharmaceuticals - RTP Business Division. Previously, he served in a number of sales and marketing roles. Prior to his current position, he served in the R&D organization of GlaxoSmithKline as Vice President and Worldwide Director of Therapeutic Development and Product Strategy-Neurology and Psychiatry. Prior to that, he was Vice President of Marketing – Infectious Diseases and Gastroenterology for Glaxo Wellcome Inc. Mr. Hull started his career in the pharmaceutical industry with SmithKline and French Laboratories in 1978. Mr. Hull is currently a member of the board of directors of several associations and has served on a variety of external committees designed to further education in the sciences.
Mr. Hull received his B.S. in Business Administration from the University of North Carolina at Greensboro.
| 